Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/56857
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBlijlevens, N.-
dc.contributor.authorLogan, R.-
dc.contributor.authorNetea, M.-
dc.date.issued2009-
dc.identifier.citationJournal of Antimicrobial Chemotherapy, 2009; 63(Supp 1):I36-I40-
dc.identifier.issn0305-7453-
dc.identifier.issn1460-2091-
dc.identifier.urihttp://hdl.handle.net/2440/56857-
dc.description© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.-
dc.description.abstractThe treatment of patients with cancer is often accompanied by life-threatening complications caused by chemotherapy and radiotherapy. They are known to result from neutropenia, but damage to the mucosal barrier as well as the humoral and cellular immune defences play a significant role in various infectious complications and aggravate diverse inflammatory processes. The article describes the journey from febrile neutropenia to febrile mucositis in patients treated with immunocompromising therapy.-
dc.description.statementofresponsibilityNicole M. A. Blijlevens, Richard M. Logan and Mihai G. Netea-
dc.language.isoen-
dc.publisherOxford Univ Press-
dc.source.urihttp://dx.doi.org/10.1093/jac/dkp081-
dc.subjectmucosal barrier injury-
dc.subjectinnate immunity-
dc.subjectinflammation-
dc.subjectcancer treatment-
dc.subjectinfections-
dc.titleMucositis: from febrile neutropenia to febrile mucositis-
dc.typeJournal article-
dc.identifier.doi10.1093/jac/dkp081-
pubs.publication-statusPublished-
dc.identifier.orcidLogan, R. [0000-0002-9331-1814]-
Appears in Collections:Aurora harvest 5
Dentistry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.